Theorem Clinical Research

Drug Sponsors

Merck to acquire Sigma-Aldrich

Monday, September 22, 2014 02:31 PM

Merck has agreed to acquire Sigma-Aldrich, a St. Louis, Mo.-based life science and technology company, for $17 billion in an all-cash transaction.

More... »


Cubist opens international headquarters in Zurich

Monday, September 22, 2014 02:25 PM

Cubist Pharmaceuticals, a company focused on novel antibiotics, has announced the official opening of its international headquarters in Zurich, Switzerland. Located in a growing biopharmaceutical hub in Switzerland, the company's international operations complement its corporate headquarters in Lexington, Mass.

More... »


Nanobiotix expands into the U.S.

Monday, September 22, 2014 02:24 PM

Nanobiotix, a Paris-headquartered clinical-stage nanomedicine company, has opened its first U.S. office in Boston.

More... »

GlaxoSmithKline to pay $485.2M fine to Chinese government in bribery scandal

Friday, September 19, 2014 01:31 PM

GlaxoSmithKline has confirmed the Changsha Intermediate People’s Court in Hunan Province, China ruled GSK China Investment (GSKCI) has, according to Chinese law, offered money or property to non-government personnel in order to obtain improper commercial gains, and has been found guilty of bribing non-government personnel. The verdict follows investigations initiated by China’s Ministry of Public Security in June 2013. 

More... »

Evotec takes legal steps against Andromeda Biotech

Friday, September 19, 2014 01:26 PM

Evotec, a Germany-based drug discovery alliance and development partnership company, will take legal steps against Israel-based Andromeda Biotech to recover all Evotec claims and potential damages that result from recent incidents in relation to DiaPep277.

More... »

Bayer plans to focus entirely on life science businesses

Thursday, September 18, 2014 01:27 PM

Bayer has announced that it intends, in the future, to focus entirely on its life science businesses—HealthCare and CropScience—and float MaterialScience on the stock market as a separate company. In this way Bayer is positioning itself as a human, animal and plant health company. The supervisory board unanimously has approved the board of management's plans.

More... »

AstraZeneca, Eli Lilly ink agreement for AZD3293 for Alzheimer’s disease

Wednesday, September 17, 2014 02:28 PM

AstraZeneca and Eli Lilly have inked an agreement to jointly develop and commercialize AZD3293, an oral beta secretase cleaving enzyme (BACE) inhibitor currently in development as a potential treatment for Alzheimer’s disease.

More... »

Endo International seeks to acquire Auxilium Pharmaceuticals for $2.2B

Wednesday, September 17, 2014 02:12 PM

Endo International, a Dublin-based global specialty healthcare company, has delivered an unsolicited proposal to acquire all of the outstanding shares of Chesterbrook, Pa.-based Auxilium Pharmaceuticals for a per share consideration of $28.10, in a cash and stock transaction valued at $2.2 billion.

More... »

Novartis to open Center for Advanced Cellular Therapeutics at University of Pennsylvania

Monday, September 15, 2014 12:29 PM

The University of Pennsylvania’s alliance with Novartis has unveiled plans for the construction of a first-of-its-kind Center for Advanced Cellular Therapeutics (CACT) on the Penn Medicine campus in Philadelphia.

More... »

Livongo Health launched

Wednesday, September 10, 2014 03:00 PM

Livongo Health, a California-based consumer digital health company, has launched with a vision to empower people with chronic conditions to live better through the combined power of technology, real-time personalized information and support from a chosen care team.

More... »

Subscribe to The CenterWatch Monthly
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 29

WCG sees ePharmaSolutions’ clinical trial portal as the next step in the data evolution, company mission

Cutting-edge advertising can ‘break through the clutter’ for successful patient recruitment

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

September

Today's fastest, most economical sponsors
Standout sponsors reveal how they shorten regulatory, clinical cycle times

From the trenches: Sites' eye view of state of the industry
CW’s first site focus groups uncover frustration with 'progress,' but a passion for their mission

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

August

Reality of costs and impact rain on Sunshine Act
Concerns mount over compliance burden on CROs, sponsors, unanticipated consequences for research

Cloud computing expanding into all areas of clinical trial conduct
Benefits outweigh the complexities, challenges of finding right vendors

Already a subscriber?
Log in to your digital subscription.

Purchase the August issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs